,VSIG4

Els Lebegge1,2, Neema Ahishakiye Jumapili1,2, Jolien Van Craenenbroeck1,2

  • 1Laboratory of Cellular and Molecular Immunology, Brussels Center for Immunology (BCIM), Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium.

Cancers
|October 16, 2025
PubMed
概括

VSIG4在人体瘤相关巨细胞 (TAMs) 中表达,并与更差的预后有关. 然而,临床前模型显示,VSIG4缺乏不会影响原发性瘤生长或肝转移,这表明这些模型的局限性.